What is Jiangxi Xinganjiang Pharmaceutical Co OCF Yield %?
Jiangxi Xinganjiang Pharmaceutical CoBJSE:920367 60 OCF Yield % is 1.29 as of Jul. 12, 2026, which is 71% below its 10-year median of 4.41. GuruFocus rates BJSE:920367 with a GF Score™ of 60/100 and a GF Value™ of ¥12.09 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 1,007 Drug Manufacturers companies, Jiangxi Xinganjiang Pharmaceutical Co ranks worse than 62.66% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Jiangxi Xinganjiang Pharmaceutical Co OCF Yield % Explanation
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Jiangxi Xinganjiang Pharmaceutical Co OCF Yield % Related Terms
Jiangxi Xinganjiang Pharmaceutical Co OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangxi Xinganjiang Pharmaceutical Co OCF Yield % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Jiangxi Xinganjiang Pharmaceutical Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jiangxi Xinganjiang Pharmaceutical Co OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jiangxi Xinganjiang Pharmaceutical Co's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Jiangxi Xinganjiang Pharmaceutical Co's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) has a OCF Yield % of 1.29 as of Jul. 12, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Jiangxi Xinganjiang Pharmaceutical Co and its competitors. This is 71% below median its historical median of 4.41. Over the past decade, Jiangxi Xinganjiang Pharmaceutical Co's OCF Yield % has ranged from 1.18 to 18.26. According to the industry distribution chart, Jiangxi Xinganjiang Pharmaceutical Co ranks #631 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 62.7%.
Is Jiangxi Xinganjiang Pharmaceutical Co's OCF Yield % too high?
Jiangxi Xinganjiang Pharmaceutical Co's current OCF Yield % of 1.29 is 71% below median its 10-year median of 4.41. Over the past 10 years, this metric has ranged from a low of 1.18 to a high of 18.26. The Drug Manufacturers industry median OCF Yield % is 3.55. Jiangxi Xinganjiang Pharmaceutical Co's value of 1.29 is 63.7% below this industry median. Based on the distribution chart, Jiangxi Xinganjiang Pharmaceutical Co ranks #631 out of 1007 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Jiangxi Xinganjiang Pharmaceutical Co has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jiangxi Xinganjiang Pharmaceutical Co's OCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jiangxi Xinganjiang Pharmaceutical Co ranks #631 out of 1007 companies for OCF Yield %. This places Jiangxi Xinganjiang Pharmaceutical Co in the lower half of its industry. The industry median OCF Yield % is 3.55. Jiangxi Xinganjiang Pharmaceutical Co's value of 1.29 is 63.7% below this benchmark. Historically, Jiangxi Xinganjiang Pharmaceutical Co's own OCF Yield % has ranged from 1.18 to 18.26 over the past decade. While the company's 10-year median is 4.41 vs. the industry median of 3.55, Jiangxi Xinganjiang Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.55, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jiangxi Xinganjiang Pharmaceutical Co's current OCF Yield % of 1.29 is 63.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Jiangxi Xinganjiang Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jiangxi Xinganjiang Pharmaceutical Co's current OCF Yield % is 1.29, which is 71% below median its own 10-year median of 4.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangxi Xinganjiang Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥12.09, compared to a current price of ¥24.45 — trading 102.2% above its estimated fair value. The current OCF Yield % is 1.29, which is 71% below median its 10-year median of 4.41 and 63.7% below the Drug Manufacturers industry median of 3.55. Jiangxi Xinganjiang Pharmaceutical Co's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367), the current OCF Yield % is 1.29 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) Overvalued in 2026?
Based on GuruFocus' analysis, Jiangxi Xinganjiang Pharmaceutical Co stock appears to be overvalued.
The current stock price of ¥24.45 is trading 102.2% above its estimated GF Value™ of ¥12.09.
GuruFocus considers Jiangxi Xinganjiang Pharmaceutical Co to be Significantly Overvalued.
Key valuation signals for BJSE:920367:
OCF Yield %: 1.29 (71% below median its 10-year median of 4.41)
GF Value™: ¥12.09 vs. price of ¥24.45 (102.2% above fair value)
Industry Position: 63.7% below the Drug Manufacturers median (#631 of 1007)
No single metric tells the full story. See the BJSE:920367 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jiangxi Xinganjiang Pharmaceutical Co Business Description
Jiangxi Xinganjiang Pharmaceutical Co Ltd conducts research and development, production, and sales of chemical raw materials, chemical preparations, and Chinese patent medicines. The company's raw material medicine products are mainly calcium gluconate, zinc gluconate, ferrous gluconate, and other gluconate series raw material medicines. Its main chemical preparations are vitamin C chewable tablets and compound Yinqiao aminomin capsules, and Phenaminokamin Tablets.
60GF Score
Get the complete analysis for BJSE:920367
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920367 has been successfully added to your 
